Computational methods are biased toward well-annotated and evolutionarily conserved genomic regions, indeed comparative analyses based on evolutionary conservation alone ignore species-specific functional elements.
The Editors felt a policy was necessary to ensure that analyses based on genomic data could be repeated just as easily, for example, as those based on polymerase chain reaction experiments; although no one today would publish the results of a polymerase chain reaction experiment without providing the sequences of the primers, this was not always the case.
Our present results, together with those of other recent phylogenetic analyses based on nuclear genomic data [ 8, 11, 29], indicate that Hexapoda is a monophyletic taxon.
The monophyletic origin of Hexapoda was called into question by phylogenetic analyses based on mitochondrial genomic data that found wingless collembolans and diplurans to be more closely related to crustaceans than to other hexapods [ 22, 23].
Thus the conclusion of no population structure from previous analyses based on limited individual or genomic sampling may be imprecise.
Our phylogenetic analyses based on sequence data and genomic characters are thus congruent in supporting the notion that the Oedogoniales diverged before the Chaetopeltidales and the Chaetophorales.
Biological systems analyses based on correlation structures are predicted to contain multiple erroneous correlations when using extant classical inbred lines because of the preexisting genomic correlations.
Computationally based genomic analyses have been able to accomplish interpretation of the genome of Caenorhabditis elegans on a global scale.
Moreover, our studies revealed a large number of previously unreported derivatives of all known A. vinelandii siderophores and rationalized their origins based on genomic analyses, with implications for siderophore diversity and evolution.
Integrated with precision medicine strategies to define key molecular vulnerabilities based on genomic analyses, our multi-scale modeling analysis of drug distribution could be instrumental in identifying corresponding targeted therapeutics with the highest likelihood of optimal drug distribution across the entire tumor cell population in an individual brain tumor.
